Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Psa Test

UCSD Experts Respond to New Guidelines for Prostate Cancer Test

Yesterday, the United States Preventive Services Task Force released a draft recommendation that states healthy men should no longer receive a P.S.A test for prostate cancer as it often leads to unnecessary testing and procedures and does not save lives.

Below is a response to the suggested new guidelines from Christopher Kane, MD, FACS,… UCSD Experts Respond to New Guidelines for Prostate Cancer Test   



PSA test valuable in predicting biopsy need, low-risk prostate cancer

The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found. The findings were released today during a meeting of the North Central Section of the American Urological Association… PSA test valuable in predicting biopsy need, low-risk prostate cancer   



Biopsy referral after PSA screening stays consistent over time

After the US Prostate Cancer Prevention Trial found cancer in many men with low levels of prostate specific antigen (PSA), many debated which PSA level should lead to a biopsy recommendation. The US Preventive Screening Task Force (USPSTF) recently concluded, amid considerable controversy, that the evidence does not support recommending PSA screening for men… Biopsy referral after PSA screening stays consistent over time   



Mass Prostate Cancer Screening Doesn’t Reduce Deaths

There’s new evidence that annual prostate cancer screening does not reduce deaths from the disease, even among men in their 50s and 60s and those with underlying health conditions, according to new research led by Washington University School of Medicine in St. Louis.

A longer follow-up of more than 76,000 men in a major… Mass Prostate Cancer Screening Doesn’t Reduce Deaths   



Prostate screening not saving lives, study says

A big study in Europe gives mixed results about prostate cancer screening that may do little to change minds about its value.

The study finds that PSA blood tests every four years seem to cut the risk of death from prostate cancer. But it also finds that screening makes no difference in overall mortality… Prostate screening not saving lives, study says   



PSA test part of trend: Fewer screenings for well people

Many men were surprised this week when a government advisory panel recommended that doctors stop using the PSA test to screen healthy men for prostate cancer.

Yet health experts say the recommendations by the U.S. Preventive Services Task Force are a part of a broader trend that’s been building for years. People are taking… PSA test part of trend: Fewer screenings for well people   



Experts disparage use of test for prostate cancer, but many men may reject advice

That was the reaction from many men last week after a top-level task force bucked two decades of medical practice and recommended against routine use of a common blood test to check for prostate cancer.

The PSA test does more harm than good, the group said. It pointed to two huge, expensive studies, which… Experts disparage use of test for prostate cancer, but many men may reject advice   



Scientists develop ‘barcode’ blood test for aggressive prostate cancer

Scientists have designed a blood test that reads genetic changes like a barcode - and can pick out aggressive prostate cancers by their particular pattern of gene activity.

A team at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust found reading the pattern of genes switched on and off… Scientists develop ‘barcode’ blood test for aggressive prostate cancer   



Urologists echo call for discussion before PSA test

Urologists fell in line with other doctor groups on Friday in recommending careful consideration and discussion when it comes to screening for prostate cancer, rather than a gung-ho approach.

At its annual meeting in San Diego, California, the American Urological Association (AUA) recommended against screening average-risk men under age 55 or any man over… Urologists echo call for discussion before PSA test   



Low risk prostate cancer not always low risk

More and more men who believe they have low-risk prostate cancers are opting for active surveillance, forgoing treatment and monitoring the cancer closely with prostate-specific antigen (PSA) tests, digital rectal exams and ultrasounds at regular intervals to see if their tumors are growing. Nearly 400 men are now enrolled in the UCLA Active Surveillance… Low risk prostate cancer not always low risk   



prostate tissue1 - phosphate stones2 - clinical journal of the american society nephrology3 - prostate cancer test1 - risk of prostate cancer2 - surface enhanced raman spectroscopy1 - standard kidney biopsy1 - early kidney damage1 - autosomal recessive polycystic kidney disease1 - lupus patients1 - protein flt11 - canadian institute of health information1 - high blood sugar1 - internal and external genitalia1 - high-precision surgical robot1 - calcium4 - cmaj2 - urs1 - congenital disorders1 - hemorrhagic inflammation1 - renal tissue1 - prostate cancer cell1 - alpha blockers1 - urinary function1 - narrowed blood vessel1 - intravenous fluids1 - external sphincter dyssynergia3 - nephrology9 - green k1 - prostate cancer survival1 -